Hormone Replacement Therapy Tied to Ovarian Cancers

A meta-analysis of 17 prospective studies, published in the Lancet looking at over 12,000 women diagnosed with ovarian cancer, about half of the women with ovarian cancer had received hormone therapy, and the median duration of use was 6 years. Women with current hormone therapy use had roughly a 40% increased risk for developing ovarian cancer, even among those who used hormone therapy for less than 5 years. The risk decreased with time, but 10 years after stopping, there was still an increased risk for certain type of tumors.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s